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Abstract
Purpose—To report our experience with protractor myectomy in patients with benign essential blepharo-
spasm who did not respond to serial botulinum toxin injection, and to describe intra- and postoperative
techniques that limited skin contracture while also providing excellent functional and cosmetic results.
Methods—The medical records of patients with isolated, benign, essential blepharospasm who underwent
protractor myectomy from 2005 to 2008 by a single surgeon were reviewed retrospectively. The technique
entailed operating on a single eyelid during each procedure, using a complete en bloc resection of all orbi-
cularis tissue, leaving all eyelid skin intact at the time of surgery, and placing the lid under stretch with
Frost suture and applying a pressure dressing for 5–7 days.
Results—Data from 28 eyelids in 7 patients were included. Average follow-up was 21.5 months (range,
4–76 months). Of the 28 eyelids, 20 (71.4%) showed postoperative resolution of spasm, with no further
need for botulinum toxin injections. In the 8 eyelids requiring further injections, the average time to injec-
tion after surgery was 194 days (range, 78–323 days), and the average number of injections was 12 (range,
2–23 injections). All but one eyelid had excellent cosmetic results, without signs of contracture; one eyelid
developed postoperative skin contracture following premature removal of the Frost suture and pressure
dressing because of concerns over increased intraocular pressure.
Conclusions—In our patient cohort, this modified technique resulted in excellent cosmetic and func-
tional results and limited postoperative skin contracture.
Introduction
Benign essential blepharospasm (BEB) is a rare disease,
with a reported incidence of 1.2 persons per 100,000
annually and prevalence of 16–133 per million.1–3 The
first-line treatment for this condition is serial botulinum
A toxin injections, which are effective for the rapid but
temporary treatment of BEB.4–13 In patients who fail to
respond to this treatment, protractor myectomy, which
has been performed routinely for decades, remains a
highly effective treatment, with few complications.14–23
Nevertheless, postoperative complications can arise,
including hemorrhage, hematoma, lid edema, lagoph-
thalmos, skin necrosis, and skin contracture.24 This
study describes intra- and postoperative techniques used
to limit the development of skin contracture while
simultaneously maintaining excellent functional and
cosmetic results.
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Subjects and Methods
The medical records of patients who underwent protrac-
tor myectomies by a single surgeon (WRN) in an ambu-
latory setting for isolated BEB from 2005 to 2008 were
reviewed retrospectively. Ethics consent was waived by
the University of Louisville Institutional Review Board
for this study, which complied with the US Health Insur-
ance Portability and Accountability Act of 1996. The
primary indication for protractor myectomy was poor
response to serial botulinum A toxin injections. The goal
of surgery in these patients suffering from blepharo-
spasm was to perform careful and complete orbiculec-
tomy of the upper and lower eyelids. Main outcome
measures were complete resolution of spasm or need for
continued botulinum toxin injections after orbiculec-
tomy, length of time between botulinum toxin injections
after orbiculectomy, and number of eyelids with cicatri-
cial retraction with symptomatic lagophthalmos. Patients
were excluded if they had undergone any previous eye-
lid surgery or if there was presence of preoperative eye-
lid retraction.
Surgical Technique
The protractor myectomy was performed in multiple
phases, in which the orbicularis was segmentally resec-
ted at each operation. The upper protractor muscles were
approached through an upper lid crease incision, similar
to that used in blepharoplasty and ptosis surgery (Figure
1A). The skin was meticulously dissected from the
underlying muscle in a plane extending superiorly to the
junction of the frontalis and orbicularis muscles, medi-
ally to the canthus and laterally to the inferior aspect of
the horizontal raphe. The orbital, preseptal, and majority
of pretarsal divisions of the orbicularis were then
removed en bloc to limit disruption of the underlying
neurovascular structures (Figure 1B). The remaining
pretarsal orbicularis muscle was carefully excised
exposing the base of the underlying eyelashes (Figure
1C), thus ensuring complete removal of all orbicularis
muscle tissue. There was no removal of any excess
upper or lower eyelid skin, and corrugator supercilli and
procerus muscles were left intact in all cases.
In the lower eyelid, the overlying skin was dissected
from the orbicularis muscle down to the inferior orbital
rim. All visualized portions of the orbicularis were
removed in a similar procedure to the upper eyelid.
Additional eyelid deformities, such as lid malposition,
brow ptosis, blepharoptosis and dermatochalasis, were
addressed at a later time, once the patient had fully
recovered from myectomy surgery. To avoid postopera-
tive skin contracture, the incision was reapproximated
using 6-0 fast-absorbing gut sutures. Subsequently, a
Frost suture and pressure dressing were applied to the
lid in the immediate postoperative period (Figure 1D).
Both were kept in place for 5–7 days to ensure that con-
stant pressure and stretch were exerted on the eyelid.
Because this surgical technique involves the use of a
Frost suture and pressure patch, a single eyelid was
operated on with each procedure.
Results
A total of 28 eyelids of 7 patients (median age, 63 years;
range, 50–93 years) were included. Average follow-up
time was 21.5 months (range, 4–76 months). Of the 28
eyelids, 20 (71.4%) showed resolution of spasm and no
longer required treatment with botulinum toxin follow-
ing orbiculectomy (Figure 2). Of the 8 eyelids that
required further treatment with botulinum toxin postop-
eratively, the average time to injection after surgery was
194 days (range, 78–323 days), and the average number
of injections each eye received was 12 (range, 2–23
injections). All but one eyelid had excellent cosmetic
results without signs of contracture. One eyelid devel-
oped postoperative contracture following premature
removal of the Frost suture and pressure dressing two
days after surgery due to concerns over increased intra-
Figure 1.  Surgical technique of protractor myectomy. A, The
upper eyelid protractor muscles are approached through a lid
crease incision. B–C, The orbital, preseptal and pretarsal divisions
of the orbicularis are removed en bloc, exposing the base of the
underlying eyelashes. D, Frost suture is applied to the eyelid in the
immediate postoperative period.
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ocular pressure (Figure 3). This contracture resulted in
persistent lagophthalmos and corneal exposure requiring
upper eyelid retraction repair with a full-thickness skin
graft.
Discussion
Botulinum A toxin is a widely accepted treatment for
BEB.4–13 Although many patients experience rapid
symptomatic relief, the effects of botulinum toxin are
temporary, and many patients develop resistance to its
effects with repeated injections. Thus, there are patients
whose symptoms are poorly controlled with botulinum
toxin injections alone.25 Complications of botulinum
toxin injections are well documented and include ptosis,
corneal exposure, lagophthalmos, symptomatic dry eye,
lid malposition, epiphora, photophobia, diplopia, ecchy-
mosis, and lower facial weakness.24–26 In addition, BEB
is associated with many eyelid deformities, including lid
malposition, brow ptosis, dermatochalasis, blepharopto-
sis, and blepharophimosis, all of which may become
more pronounced following botulinum toxin injec-
tions.24 Furthermore, many patients are unwilling or
unable to undergo long-term serial injections. Therefore,
in patients who experience side effects, are unable to
undergo serial injections, or develop relative resistance
Figure 2.  Demonstration of improvement of blepharospasm after
protractor myectomy. A, Preoperative photograph showing severe
blepharospasm. B, Marked improvement 6 months after bilateral
upper and lower eyelid myectomy surgery.
to injections the use of protractor myectomy is seen as a
definitive treatment for BEB.14–23
In a long-term study of patients with botulinum toxin
resistant BEB in whom subtotal myectomy was pre-
formed, Chapman et al showed that myectomy provided
subjective improvement and decreased the long-term
need for injections in over 50% of patients.15 Anderson
et al reported that in 330 patients who received upper
eyelid myectomy or upper and lower eyelid myectomy,
88% noted improvement with only 38% requiring injec-
tions after full myectomy.24 McCord et al17 comparing
facial nerve avulsion to an eyebrow-eyelid muscle strip-
ping procedure reported that secondary procedures were
required 4.5 times more often with the facial nerve avul-
sion and that patients’ subjective response to and accept-
ance of myectomy was much greater.
Studies have also suggested that patients who require
botulinum toxin after myectomy often require fewer
injections overall, and experience longer periods of
relief between injections.27 In a study of 14 patients who
underwent myectomy for BEB, Mauriello et al27 found
Figure 3.  Demonstration of postoperative skin contracture. A,
Preoperative picture demonstrating severe blepharospasm that was
unresponsive to serial botulinum toxin injections. B, Improvement
of blepharospasm 3 months following bilateral upper and lower
eyelid myectomy surgery. C, The right upper eyelid developed
postoperative contracture following premature removal of Frost
suture and pressure dressing 2 days after surgery.
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that the average duration of effect of injections increased
from 122.1 days in the patients prior to undergoing eye-
lid surgery to 210.5 days after surgery. In concordance
with these studies, our results revealed that 71.4% (20 of
28) of eyelids did not, within the study period, require
additional botulinum toxin treatments following myec-
tomy surgery. Additionally, in those patients requiring
reinjection after surgery, the average time to repeat
injection was approximately 6 months (194 days). We
attribute these encouraging results to our new treatment
paradigm and the associated intra- and postoperative
techniques used in these patients.
We recognize that this study is not without limitations.
The small sample size and retrospective nature limit our
ability to report on the long-term effect of the myectomy
procedure described above.
Given that myectomy has been successfully preformed
for decades with favorable results, debate still exists as
to the extent of muscle removal (partial vs complete),
the timing and sequence of myectomy (simultaneous vs
staged), on which lid to operate (upper vs lower), and
whether removal of eyelid skin is necessary.14–16,24,28
The technique we describe represents a new perspective
on the protractor myectomy procedure. We view the sur-
gery as creation of an in situ full-thickness skin graft and
approach our postoperative care accordingly. The com-
plete separation of the orbicularis oculi from the overly-
ing epidermis and dermis disrupts normal perfusion to
the overlying skin. Disruption of this process can lead to
partial or total necrosis and scar contracture. Further-
more, the natural course of full-thickness skin grafts is
to undergo primary contraction during healing. There-
fore, measures must be taken to ensure appropriate neo-
vascularization occurs to reduce the occurrence of con-
tracture. We achieve this through the use of Frost sutures
and pressure dressings for 5–7 days to place tension on
the eyelid and limit primary contraction. In addition,
concurrent excess skin removal procedures are delayed
until a later date if needed. Because a Frost suture and
pressure dressing are used, only a single eyelid is oper-
ated on at each procedure, and the muscle is removed en
bloc to ensure complete resection of the entire orbicula-
ris.
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